Valuation Singapore Institute of Advanced Medicine Holdings Ltd.
Stocks
9G2
SGXE79544776
Healthcare Facilities & Services
|
Market Closed -
Singapore S.E.
19:58:29 2026-11-01 EST
|
5-day change | 1st Jan Change | ||
| 0.0230 SGD | 0.00% |
|
+4.55% | -66.67% |
Company Valuation: Singapore Institute of Advanced Medicine Holdings Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: June | 2024 | 2025 | 2026 |
|---|---|---|---|
| Market Cap 1 | 105.9 | 30.8 | 51.72 |
| Change | - | -70.91% | 67.94% |
| Enterprise Value (EV) 1 | 148.7 | 85.63 | 97.6 |
| Change | - | -42.43% | 13.98% |
| P/E | -2.22x | -1.13x | -1.5x |
| PBR | 1.29x | 0.55x | 0.98x |
| PEG | -0x | 0x | 0.1x |
| Capitalization / Revenue | 6.36x | 1.96x | 3.29x |
| EV / Revenue | 8.94x | 5.45x | 6.21x |
| EV / EBITDA | -13.3x | -6.73x | -7.99x |
| EV / EBIT | -7.17x | -3.95x | -4.96x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.0455 | -0.0257 | -0.0201 |
| Distribution rate | - | - | - |
| Net sales 1 | 16.65 | 15.71 | 15.72 |
| EBITDA 1 | -11.22 | -12.72 | -12.21 |
| EBIT 1 | -20.73 | -21.7 | -19.69 |
| Net income 1 | -37.45 | -27.05 | -23.9 |
| Net Debt 1 | 42.89 | 54.83 | 45.88 |
| Reference price 2 | 0.1010 | 0.0290 | 0.0300 |
| Nbr of stocks (in thousands) | 1,048,099 | 1,062,021 | 1,724,092 |
| Announcement Date | 12/11/24 | 10/12/25 | 10/14/26 |
1SGD in Million2SGD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 31.03M | ||
| 13.15x | 0.4x | 8.38x | 2.95% | 115B | ||
| 15.63x | 1.89x | 9.41x | 0.66% | 98.85B | ||
| -288.65x | 20.15x | -340.61x | -.--% | 59.72B | ||
| 14.48x | 1.57x | 9.5x | 2.44% | 30.06B | ||
| 26.78x | 2.33x | 13.22x | 0.8% | 29.34B | ||
| 24.39x | 2.71x | 13.74x | 1.31% | 27.71B | ||
| 7.51x | 1.45x | 6.4x | -.--% | 21.75B | ||
| 29.58x | 5.3x | 21.64x | 2.36% | 19.96B | ||
| 30.38x | 2.86x | 12.88x | 1.46% | 17.09B | ||
| Average | -14.08x | 4.29x | -27.27x | 1.33% | 41.99B | |
| Weighted average by Cap. | -26.21x | 4.32x | -39.53x | 1.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 9G2 Stock
- Valuation Singapore Institute of Advanced Medicine Holdings Ltd.
Select your edition
All financial news and data tailored to specific country editions
















